The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer.

@article{Gioulbasanis2012TheGP,
  title={The Glasgow Prognostic Score (GPS) predicts toxicity and efficacy in platinum-based treated patients with metastatic lung cancer.},
  author={Ioannis Gioulbasanis and Athanasios A. Pallis and Panagiotis J. Vlachostergios and Alexandros Xyrafas and Zoe Giannousi and Isidora-Eleni Perdikouri and Michalitsa Makridou and Dionysia Kakalou and Vassilios Georgoulias},
  journal={Lung cancer},
  year={2012},
  volume={77 2},
  pages={383-8}
}
PURPOSE Lung cancer is the most common cause of cancer death. A cumulative prognostic score based on C-reactive protein and albumin, termed the Glasgow Prognostic Score (GPS), indicates the presence of systemic inflammatory response. GPS has been proposed as a powerful prognostic tool for patients with various types of malignant tumors, including lung cancer. The aim of this study was to assess the predictive value of baseline GPS in terms of toxicity and response in lung cancer patients… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 18 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…